Johan Jemberang
Research Subjects
Research Interests
Johan Jemberang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Najib Hasan
Clinical Laboratory Science Section , Universiti Kuala Lumpur Institute of Medical Science Technology , A1-1, Jalan TKS 1, Taman Kajang Sentral, 43000 Kajang , Selangor , Malaysia
1 shared publication - Ahmad Sabry Mohamad
Section of Medical Engineering Technology, Universiti Kuala Lumpur British Malaysian Institute, 53100 Selangor, Malaysia
1 shared publication - Ismail Che Ani
Herbs Research Centre , No.1, Jalan 3 Taman Pinggiran USJ, 47610 Sugang Jaya , Selangor , Malaysia
1 shared publication - Mohd Rahman Omar
Medical-Based Department, Faculty of Medicine & Health Sciences, Universiti Sains Islam Malaysia (USIM), Nilai, Negeri Sembilan, Malaysia
1 shared publication - Muhammad Imran Ahmad
Department of Pharmacology , Universiti Kuala Lumpur Royal College of Medicine Perak , Jalan Greentown, 30450 Ipoh , Perak , Malaysia
1 shared publication - Muhammad Noor Nordin
Medical Section, British Malaysian Institute, Universiti Kuala Lumpur, Gombak 53100, Selangor, Malaysia
1 shared publication
Latest Publications
- Open Access
- 1 December 2021
- Published by Index Copernicus in Herba Polonica
- Vol. 67 (4) , 42-53
Preliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysis
Summary: Introduction: Volten VR4® capsules containing herb extract of Kaempferia parviflora has been claimed to reduce blood glucose in patients with diabetes. Objectives: This preliminary study is conducted to evaluate the efficacy of Volten VR4® on healthy individuals and type-2 diabetes mellitus volunteers. The extracts of 400 mg capsules of Kaempferia parviflora (KP) were used to measure the blood glucose level of 2-hour postprandial. Methods: The healthy group consists of 15 young adults aged 20-30 with no history of serious diseases, while the diabetic group includes 12 individuals aged 35-75 diagnosed with type-2 diabetes mellitus. Data were validated through the Willcoxon and Friedman test statistics and error distribution. The investigation was continued to trace the capsules contents of elements using inductively coupled plasma optical emission spectrometry (ICP-OES) techniques. Results: It has been shown that KP reducing blood sugar levels has been associated with flavonoids and methoxyflavones components. The result specifically showed that consuming VR4® capsules can significantly reduce blood glucose, either at the state of fasting or postprandially. In the study the content of mineral and heavy metal elements in VR4® capsules has been evaluated. Conclusion: Volten VR4® Kaempferia parviflora extract is safe to be consumed at a single dose of 400 mg. The study also has shown that the participants are free from adverse reactions and hypoglycaemia.
- 1 December 2021
- Published by Index Copernicus in Herba Polonica
- Vol. 67 (4) , 42-53
Open AccessPreliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysis
Summary: Introduction: Volten VR4® capsules containing herb extract of Kaempferia parviflora has been claimed to reduce blood glucose in patients with diabetes. Objectives: This preliminary study is conducted to evaluate the efficacy of Volten VR4® on healthy individuals and type-2 diabetes mellitus volunteers. The extracts of 400 mg capsules of Kaempferia parviflora (KP) were used to measure the blood glucose level of 2-hour postprandial. Methods: The healthy group consists of 15 young adults aged 20-30 with no history of serious diseases, while the diabetic group includes 12 individuals aged 35-75 diagnosed with type-2 diabetes mellitus. Data were validated through the Willcoxon and Friedman test statistics and error distribution. The investigation was continued to trace the capsules contents of elements using inductively coupled plasma optical emission spectrometry (ICP-OES) techniques. Results: It has been shown that KP reducing blood sugar levels has been associated with flavonoids and methoxyflavones components. The result specifically showed that consuming VR4® capsules can significantly reduce blood glucose, either at the state of fasting or postprandially. In the study the content of mineral and heavy metal elements in VR4® capsules has been evaluated. Conclusion: Volten VR4® Kaempferia parviflora extract is safe to be consumed at a single dose of 400 mg. The study also has shown that the participants are free from adverse reactions and hypoglycaemia.